Metraipolis › archive › dc_eaa5bd68aab5
Comparative atrial fibrillation risk across Bruton's tyrosine kinase inhibitors in B-cell malignancies: A nationwide population-based study — Europe PMC PMID:42334369
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42334369
- DOI
- 10.1111/bjh.70634
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T06:21:34.649Z
- SHA-256 of the archived text
e929438f12dfc0d2a40beccf1557027a43c313e117defdffce912357951bb3ca- Stable URL of this page
https://metraipolis.com/documento/dc_eaa5bd68aab5
How to cite
Comparative atrial fibrillation risk across Bruton's tyrosine kinase inhibitors in B-cell malignancies: A nationwide population-based study — Europe PMC PMID:42334369 — Europe PMC (en), https://europepmc.org/article/MED/42334369 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eaa5bd68aab5 (Metraipolis archive dc_eaa5bd68aab5, sha256 e929438f12dfc0d2a40beccf1557027a43c313e117defdffce912357951bb3ca)
BibTeX
@misc{dceaa5bd68aab5,
title = {Comparative atrial fibrillation risk across Bruton's tyrosine kinase inhibitors in B-cell malignancies: A nationwide population-based study — Europe PMC PMID:42334369},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42334369},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eaa5bd68aab5; sha256 e929438f12dfc0d2a40beccf1557027a43c313e117defdffce912357951bb3ca},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42334369. Agents can read the archived copy with the MCP tool read_document.